Epoch Biodesign uses enzymes to break down plastic waste into monomers for new plastic production.
About
Epoch Biodesign is a biotechnology company focused on developing enzymatic solutions for plastic recycling. Their technology utilizes engineered enzymes to depolymerize plastic waste into its constituent monomers, which can then be used to create virgin-quality new plastics. This approach offers a more sustainable and circular method for managing plastic waste compared to traditional recycling or disposal methods.
Tags
Score Breakdown
58Traction
39Team
0Visibility
13Profile
0Community
15Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Epoch Biodesign do?
Epoch Biodesign is a biotechnology company focused on developing enzymatic solutions for plastic recycling. Their technology utilizes engineered enzymes to depolymerize plastic waste into its constituent monomers, which can then be used to create virgin-quality new plastics. This approach offers a more sustainable and circular method for managing plastic waste compared to traditional recycling or disposal methods.
How much funding has Epoch Biodesign raised?
Epoch Biodesign has raised a total of $12M in funding. The most recent round on record is Funding Round.
Where is Epoch Biodesign headquartered?
Epoch Biodesign is headquartered in Cambridge, Massachusetts, United States.
When was Epoch Biodesign founded?
Epoch Biodesign was founded in 2021.
What industry does Epoch Biodesign operate in?
Epoch Biodesign operates in Biotechnology, Chemicals, Sustainability, Circular Economy, Waste Management.
Similar Startups